WAYRILZ 400 mg/1
rilzabrutinib · TABLET, FILM COATED · Genzyme Corporation
No Recall History
Plain English
WAYRILZ is a tablet, film coated containing rilzabrutinib at 400 mg/1, taken oral. Manufactured by Genzyme Corporation.
Key Facts
- Brand Name
- WAYRILZ
- Generic Name
- rilzabrutinib
- NDC Code (Product)
58468-0251- Manufacturer
- Genzyme Corporation
- Strength
- 400 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA219685
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 08/29/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is WAYRILZ used for?
WAYRILZ contains rilzabrutinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is WAYRILZ a controlled substance?
WAYRILZ is not classified as a controlled substance by the DEA.
What is the generic name for WAYRILZ?
The generic name for WAYRILZ is rilzabrutinib. There are no other listed brand versions of rilzabrutinib.
What is the NDC code for WAYRILZ 400 mg/1?
The NDC (National Drug Code) for WAYRILZ 400 mg/1 is 58468-0251, listed by Genzyme Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)